Medicina de Família
Estudo de coorte | Não foi encontrada nenhuma associação entre terapia com estatinas e declínio cognitivo ou incidência de demência em idosos.
23 Jun, 2021 | 10:52hComentários: Statin Therapy Not Associated With Cognitive Decline, Dementia in Older Adults, Study Says – American College of Cardiology E Effect of Statins on Cognitive Decline and Dementia in Older Adults – American College of Cardiology
Análise do especialista | Prevenção global de doença cardiovascular entre pessoas diabéticas.
23 Jun, 2021 | 10:50hPublicação original e fontes: The Global Diabetes Compact – World Health Organization
Ver também: The WHO Global Diabetes Compact: a new initiative to support people living with diabetes – The Lancet Diabetes & Endocrinology (necessário cadastro gratuito)
Editorial | Fisioterapeutas podem reduzir o uso excessivo de intervenções com o Choosing Wisely.
23 Jun, 2021 | 10:48hPhysiotherapists can reduce overuse by Choosing Wisely – Journal of Physiotherapy
Veja a lista completa de práticas de baixo valor: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia E Choosing Wisely Canada
[Preprint] Rápida substituição da variante B.1.1.7 (Alfa) do SARS-CoV-2 pelas variantes B.1.617.2 (Delta) e P.1 (Gama) nos Estados Unidos.
22 Jun, 2021 | 09:14hRapid displacement of SARS-CoV-2 variant B.1.1.7 by B.1.617.2 and P.1 in the United States – medRxiv
Comentário no Twitter
🆕💥💥Preprint
📌B.1.617.2 Delta and P.1 are growing faster than B.1.1.7 & B.1.617.2 is growing faster than P.1 in the US
📌B.1.617.2 will soon be the dominant variant in the US
📌B.1.617.2 is growing more rapidly in counties with lower vaccination rateshttps://t.co/6Rf3p5N4ed pic.twitter.com/sVzyQRXn12— Antibiotic Steward 🇵🇸💔Bassam Ghanem (@ABsteward) June 22, 2021
Ivermectina é a nova hidroxicloroquina, parte 2 – “Ivermectina não deve ser usada no tratamento da COVID-19 fora do contexto de um estudo clínico.”
22 Jun, 2021 | 09:11hIvermectin is the new hydroxychloroquine, take 2 – Science-Based Medicine
Relacionado: [Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance E M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection E Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials E EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomized clinical trials E FDA: Why you should not use Ivermectin to treat or prevent COVID-19 E RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19 E NIH Guideline Statement: “there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19” E Video (5min): Ivermectin for COVID-19 | A Doctor Explains
Relato de caso | Síndrome inflamatória multissistêmica em adulto após infecção por SARS-CoV-2.
22 Jun, 2021 | 09:09hSinopse de diretriz | Tratamento da pressão arterial em pacientes com doença renal crônica não dialítica.
22 Jun, 2021 | 09:08hDiretriz original: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
Comentário: Guideline issued on blood pressure management in CKD – ACP Internist
Estudo mostra excesso de uso de levotiroxina em pacientes com hipotireoidismo subclínico, apesar das evidências mostrarem que não há benefício.
22 Jun, 2021 | 09:05hLevothyroxine Use in the United States, 2008-2018 (gratuito por tempo limitado)
Editorial: Overuse of Levothyroxine in Patients With Subclinical Hypothyroidism: Time to “Leve”-Out-Thyroxine – JAMA Internal Medicine (gratuito por tempo limitado)
Relacionado: RCT: Levothyroxine does not reduce the risk of developing depressive symptoms in older adults with subclinical hypothyroidism (estudos e diretrizes sobre o tema)
Análise do especialista | O papel cada vez maior do escore de cálcio das artérias coronárias na prevenção primária.
22 Jun, 2021 | 09:04h
Comentário no Twitter
New ACC Expert Analysis: The Ever-Growing Role of Coronary Artery Calcium in Primary Prevention.
More: https://t.co/GSsEqkoMbi @miguelcainzos23 @rblument1 @AndyGagel #ASCVD #cvPrev pic.twitter.com/7cUOAIArz9
— American College of Cardiology (@ACCinTouch) June 22, 2021
Dados da Inglaterra mostram que o risco de reinfecção por Covid-19 é baixo – “Houve 15.893 possíveis reinfecções pelo SARS-CoV-2 identificadas até 30/5/2021 na Inglaterra ao longo da pandemia, em cerca de 4 milhões de pessoas com infecções confirmadas. Isso equivale a aproximadamente 0,4% de casos de reinfecção.”
21 Jun, 2021 | 11:03hNew national surveillance of possible COVID-19 reinfection, published by PHE – Public Health England
Relacionado: Had COVID? You’ll probably make antibodies for a lifetime – Nature E COVID-19 reinfection rate less than 1 percent for those with severe illness, study finds. E Study shows low risk of SARS-CoV-2 reinfection 1 year after primary infection.